Amalgent Therapeutics
Phase 1Repurposing Existing Drugs to Make Pain Relief Safer
Founded
2020
Focus
Small Molecules
About
Repurposing Existing Drugs to Make Pain Relief Safer
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedMar 15, 2022
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile